Genome-wide methylome analyses reveal novel epigenetic regulation patterns in schizophrenia and bipolar disorder

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Li, Yongsheng ^a   Camarillo, Cynthia ^b   Xu, Juan ^a   Arana, Tania Bedard ^b   Xiao, Yun ^a   Zhao, Zheng ^a   Chen, Hong ^a   Ramirez, Mercedes ^b   Zavala, Juan ^b   Escamilla, Michael A ^b   Armas, Regina ^c   Mendoza, Ricardo ^d   Ontiveros, Alfonso ^e   Nicolini, Humberto ^f   Magaña, Alvaro Antonio Jerez ^g   Rubin, Lewis P ^b   Li, Xia ^a   Xu, Chun ^a,b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Texas Tech University Health Sciences Center El Paso   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UCLA MEDICAL CENTER   (United States)

^e Instituto de Informacion de Investigacion en Salud Mental   (Mexico)

^f Medical and Family Research Group Carracci SC   (Mexico)

^g Centro Internacional de Trastornos Afectivos Y de la Conducta Adictiva (CITACA)   (Guatemala)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADULT; ARTICLE; BIPOLAR DISORDER; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DEVELOPMENTAL DISORDER; DNA DETERMINATION; DNA FLANKING REGION; DNA METHYLATION; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE REPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HISPANIC; HUMAN; MALE; MENTAL DISEASE; MEXICO; PREFRONTAL CORTEX; PROMOTER REGION; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA; UNITED STATES; YOUNG ADULT; CHROMOSOME MAP; EPIDEMIOLOGY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; HUMAN GENOME; MIDDLE AGED;

ADULT; BIPOLAR DISORDER; CHROMOSOME MAPPING; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; MALE; MIDDLE AGED; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84924045624     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/201587     Document Type: Article

References (59)

1. V. Labrie, S. Pai, and A. Petronis, "Epigenetics of major psychosis: progress, problems and perspectives," Trends in Genetics, vol. 28, no. 9, pp. 427-435, 2012.
2. H.M. Abdolmaleky, S. Thiagalingam, and M. Wilcox, "Genetics and epigenetics in major psychiatric disorders: dilemmas, achievements, applications, and future scope,"American Journal of PharmacoGenomics, vol. 5, no. 3, pp. 149-160, 2005.
3. N. Craddock,M. C. O'Donovan, and M. J. Owen, "The genetics of schizophrenia and bipolar disorder: dissecting psychosis," Journal of Medical Genetics, vol. 42, no. 3, pp. 193-204, 2005.
4. I. Kushima, B. Aleksic, Y. Ito et al., "Association study of ubiquitin-specific peptidase 46 (USP46) with bipolar disorder and schizophrenia in a Japanese population," Journal of Human Genetics, vol. 55, no. 3, pp. 133-136, 2010.
5. I.-P. Yang, H.-L. Tsai, M.-F. Hou et al., "MicroRNA-93 inhibits tumor growth and early relapse of human colorectal cancer by affecting genes involved in the cell cycle," Carcinogenesis, vol. 33, no. 8, pp. 1522-1530, 2012.
6. N. Craddock and M. J. Owen, "Rethinking psychosis: the disadvantages of a dichotomous classification nowoutweigh the advantages," World Psychiatry, vol. 6, no. 2, pp. 84-91, 2007.
7. R. Pidsley and J. Mill, "Epigenetic studies of psychosis: current findings, methodological approaches, and implications for postmortem research," Biological Psychiatry, vol. 69, no. 2, pp. 146-156, 2011.
8. Y. Kuwahara, A. Charboneau, E. S. Knudsen, and B. E. Weissman, "Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21CIP1/WAF1- dependent mechanism," Cancer Research, vol. 70, no. 5, pp. 1854-1865, 2010.
9. J. F. Costello, "DNA methylation in brain development and gliomagenesis," Frontiers in Bioscience, vol. 8, pp. s175-s184, 2003.
10. J. U. Guo, D. K. Ma, H. Mo et al., "Neuronal activity modifies the DNA methylation landscape in the adult brain," Nature Neuroscience, vol. 14, no. 10, pp. 1345-1351, 2011.
11. F. D. Lubin, T. L. Roth, and J. D. Sweatt, "Epigenetic regulation of bdnf gene transcription in the consolidation of fearmemory," Journal of Neuroscience, vol. 28, no. 42, pp. 10576-10586, 2008.
12. K. Iwamoto and T. Kato, "Epigenetic profiling in schizophrenia and major mental disorders," Neuropsychobiology, vol. 60, no. 1, pp. 5-11, 2009.
13. N. Tsankova, W. Renthal, A. Kumar, and E. J. Nestler, "Epigenetic regulation in psychiatric disorders," Nature Reviews Neuroscience, vol. 8, no. 5, pp. 355-367, 2007.
14. H. M. Abdolmaleky, K.-H. Cheng, A. Russo et al., "Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report," American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, vol. 134, no. 1, pp. 60-66, 2005.
15. D. R. Grayson, X. Jia, Y. Chen et al., "Reelin promoter hypermethylation in schizophrenia," Proceedings of theNational Academy of Sciences of the United States of America, vol. 102, no. 26, pp. 9341-9346, 2005.
16. K. Iwamoto, M. Bundo, K. Yamada et al., "DNAmethylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia," Journal of Neuroscience, vol. 25, no. 22, pp. 5376-5381, 2005.
17. A. Tolosa, J. Sanjuán, A. M. Dagnall, M. D. Moltó, N. Herrero, and R. de Frutos, "FOXP2 gene and language impairment in schizophrenia: association and epigenetic studies," BMC Medical Genetics, vol. 11, article 114, 2010.
18. J. Mill, T. Tang, Z. Kaminsky et al., "Epigenomic profiling reveals DNA-methylation changes associated with major psychosis," American Journal of Human Genetics, vol. 82, no. 3, pp. 696-711, 2008.
19. A. Petronis, I. I. Gottesman, P. Kan et al., "Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance?" Schizophrenia Bulletin, vol. 29, no. 1, pp. 169-178, 2003.
20. G. Kuratomi, K. Iwamoto, M. Bundo et al., "Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins," Molecular Psychiatry, vol. 13, no. 4, pp. 429-441, 2008.
21. E. L. Dempster, R. Pidsley, L. C. Schalkwyk et al., "Diseaseassociated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder," Human Molecular Genetics, vol. 20, no. 24, Article ID ddr416, pp. 4786-4796, 2011.
22. K. A. Aberg, J. L. McClay, S. Nerella et al., "MBD-seq as a costeffective approach for methylome-wide association studies: demonstration in 1500 case-control samples," Epigenomics, vol. 4, no. 6, pp. 605-621, 2012.
23. T. A. Down, V. K. Rakyan, D. J. Turner et al., "A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis," Nature Biotechnology, vol. 26, no. 7, pp. 779-785, 2008.
24. Y. Ruike, Y. Imanaka, F. Sato, K. Shimizu, and G. Tsujimoto, "Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing," BMC Genomics, vol. 11, no. 1, article 137, 2010.
25. R. A. Irizarry, C. Ladd-Acosta, B. Wen et al., "The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specificCpGisland shores,"NatureGenetics, vol. 41, no. 2, pp. 178-186, 2009.
26. S. Gonzalez, C. Xu, M. Ramirez et al., "Suggestive evidence for association between L-type voltage-gated calcium channel (CACNA1C) gene haplotypes and bipolar disorder in Latinos: a family-based association study," Bipolar Disorders, vol. 15, no. 2, pp. 206-214, 2013.
27. L. Migliore and F. Coppedè, "Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases," Mutation Research, vol. 667, no. 1-2, pp. 82-97, 2009.
28. Y. Zhang, T. Liu, C. A. Meyer et al., "Model-based analysis of ChIP-Seq (MACS)," Genome Biology, vol. 9, no. 9, article R137, 2008.
29. A. Mortazavi, E. M. Schwarz, B. Williams et al., "Scaffolding a Caenorhabditis nematode genome with RNA-seq," Genome Research, vol. 20, no. 12, pp. 1740-1747, 2010.
30. V. K. Mootha, C. M. Lindgren, K.-F. Eriksson et al., "PGC- 1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes," Nature Genetics, vol. 34, no. 3, pp. 267-273, 2003.
31. M. P. Ball, J. B. Li, Y. Gao et al., "Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells," Nature Biotechnology, vol. 27, no. 4, pp. 361-368, 2009.
32. R. Lister, M. Pelizzola, R. H. Dowen et al., "Human DNA methylomes at base resolution show widespread epigenomic differences," Nature, vol. 462, no. 7271, pp. 315-322, 2009.
33. G. Deng, A. Nguyen, H. Tanaka et al., "Regional hypermethylation and global hypomethylation are associated with altered chromatin conformation and histone acetylation in colorectal cancer," International Journal of Cancer, vol. 118, no. 12, pp. 2999-3005, 2006.
34. Y. Loe-Mie, A.-M. Lepagnol-Bestel, G. Maussion et al., "SMARCA2 and other genome-wide supported schizophreniaassociated genes: regulation by REST/NRSF, network organization and primate-specific evolution," Human Molecular Genetics, vol. 19, no. 14, pp. 2841-2857, 2010.
35. K. W. Lee, P. S. Woon, Y. Y. Teo, and K. Sim, "Genome wide association studies (GWAS) and copy number variation (CNv) studies of the major psychoses: what have we learnt?" Neuroscience and Biobehavioral Reviews, vol. 36, no. 1, pp. 556-571, 2012.
36. M. Koga, H. Ishiguro, S. Yazaki et al., "Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia," Human Molecular Genetics, vol. 18, no. 13, pp. 2483-2494, 2009.
37. A. Caspi, T. E. Moffitt, M. Cannon et al., "Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction," Biological Psychiatry, vol. 57, no. 10, pp. 1117-1127, 2005.
38. Y. Koga, M. Pelizzola, E. Cheng et al., "Genome-wide screen of promoter methylation identifies novel markers in melanoma," Genome Research, vol. 19, no. 8, pp. 1462-1470, 2009.
39. A. P. Feinberg and B. Tycko, "The history of cancer epigenetics," Nature Reviews Cancer, vol. 4, no. 2, pp. 143-153, 2004.
40. N. Elango and S. V. Yi, "Functional relevance of CpG island length for regulation of gene expression," Genetics, vol. 187, no. 4, pp. 1077-1083, 2011.
41. M. Kinoshita, S. Numata, A. Tajima et al., "DNA methylation signatures of peripheral leukocytes in schizophrenia," Neuro- Molecular Medicine, vol. 15, no. 1, pp. 95-101, 2013.
42. M. Weber, I. Hellmann, M. B. Stadler et al., "Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome," Nature Genetics, vol. 39,no. 4, pp. 457-466, 2007.
43. S. Saxonov, P. Berg, and D. L. Brutlag, "A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 5, pp. 1412-1417, 2006.
44. M. Escamilla, E. Hare, A. M. Dassori et al., "A schizophrenia gene locus on chromosome 17q21 in a new set of families of Mexican and Central American ancestry: evidence from the NIMH genetics of schizophrenia in Latino populations study," TheAmerican Journal of Psychiatry, vol. 166, no. 4, pp. 442-449, 2009.
45. S.-B. Xu, Y.-P. Zhu, Y.-P. Mou, and L.-H. Zhu, "Construction ofmiRNA expression vector dual-targeting on HIF-1α/survivin genes and its effects on proliferation of pancreatic cancer Panc- 1 cell line," Zhejiang Da Xue Xue Bao. Yi Xue Ban, vol. 41, no. 1, pp. 81-88, 2012.
46. A. C. Need, R. S. E. Keefe, D. Ge et al., "Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis," European Journal of Human Genetics, vol. 17, no. 7, pp. 946-957, 2009.
47. H.K. Tiwari, A. Patki, J. Lieberman et al., "Association of allelic variation in genes mediating aspects of energy homeostasis with weight gain during administration of antipsychotic drugs (CATIE study)," Frontiers in Genetics, vol. 2, article 56, 2011.
48. D. K. Putnam, J. Sun, and Z. Zhao, "Exploring schizophrenia drug-gene interactions through molecular network and pathwaymodeling," AMIAAnnual Symposium Proceedings, vol. 2011, pp. 1127-1133, 2011.
49. S. F. Cooke and M. F. Bear, "Stimulus-selective response plasticity in the visual cortex: an assay for the assessment of pathophysiology and treatment of cognitive impairment associated with psychiatric disorders," Biological Psychiatry, vol. 71, no. 6, pp. 487-495, 2012.
50. F. Yasuno, T. Suhara, T. Ichimiya, A. Takano, T. Ando, and Y. Okubo, "Decreased 5-HT1A receptor binding in amygdala of schizophrenia," Biological Psychiatry, vol. 55,no. 5, pp. 439-444, 2004.
51. J. H. Kim, S. M. Dhanasekaran, J. R. Prensner et al., "Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer," Genome Research, vol. 21, no. 7, pp. 1028-1041, 2011.
52. M. Belakavadi, J. Dell, G. J. Grover, and J. D. Fondell, "Thyroid hormone suppression of β-amyloid precursor protein gene expression in the brain involves multiple epigenetic regulatory events," Molecular and Cellular Endocrinology, vol. 339, no. 1-2, pp. 72-80, 2011.
53. C. Erbel-Sieler, C. Dudley, Y. Zhou et al., "Behavioral and regulatory abnormalities in mice deficient in the NPAS1 and NPAS3 transcription factors," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 37, pp. 13648-13653, 2004.
54. O. A. Burmistrova, A. Y. Goltsov, L. I. Abramova, V. G. Kaleda, V. A. Orlova, and E. I. Rogaev, "MicroRNA in schizophrenia: genetic and expression analysis of miR-130b (22q11)," Biochemistry, vol. 72, no. 5, pp. 578-582, 2007.
55. Y. Xiao, C. Camarillo, Y. Ping et al., "The DNAmethylome and transcriptome of different brain regions in schizophrenia and bipolar disorder," PLoS ONE, vol. 9, no. 4, Article ID e95875, 2014.
56. M. M. Nöthen, V. Nieratschker, S. Cichon, and M. Rietschel, "New findings in the genetics of major psychoses," Dialogues in Clinical NeuroSciences, vol. 12, no. 1, pp. 85-93, 2010.
57. D. Malhotra and J. Sebat, "CNvs: harbingers of a rare variant revolution in psychiatric genetics," Cell, vol. 148, no. 6, pp. 1223-1241, 2012.
58. K. A. Aberg, J. L. McClay, S. Nerella et al., "Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults," JAMA Psychiatry, vol. 71, no. 3, pp. 255-264, 2014.
59. S. Nohesara, M. Ghadirivasfi, S. Mostafavi et al., "DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder," Journal of Psychiatric Research, vol. 45, no. 11, pp. 1432-1438, 2011.